These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 31940451)

  • 1. Revised guidelines for Australian laboratories performing mycobacteriology testing.
    Bastian I; Shephard L; Lumb R;
    Commun Dis Intell (2018); 2020 Jan; 44():. PubMed ID: 31940451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for Australian mycobacteriology laboratories.
    National Tuberculosis Advisory Committee
    Commun Dis Intell Q Rep; 2006; 30(1):116-28. PubMed ID: 16637240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mycobacterial tests].
    Takashima T; Higuchi T
    Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Isolation rate of Mycobacterium tuberculosis complex from patients with suspected tuberculosis and identification of the strains with BACTEC™ NAP and immunochromatographic TB Ag MPT64 Rapid™ Tests].
    Kurtoğlu MG; Ozdemir M; Keşli R; Ozkalp B; Baysal B
    Mikrobiyol Bul; 2011 Apr; 45(2):266-73. PubMed ID: 21644069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring the performance of mycobacteriology laboratories: a proposal for standardized indicators.
    McCarthy KD; Metchock B; Kanphukiew A; Monkongdee P; Sinthuwattanawibool C; Tasaneeyapan T; Rienthong S; Ngamlert K; Srisuwanvilai LO; Varma JK
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1015-20. PubMed ID: 18713498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The added value of a European Union tuberculosis reference laboratory network--analysis of the national reference laboratory activities.
    Drobniewski FA; Nikolayevskyy V; Hoffner S; Pogoryelova O; Manissero D; Ozin AJ
    Euro Surveill; 2008 Mar; 13(12):. PubMed ID: 18761994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of the diagnostic retooling process in national TB reference laboratories, with special focus on rapid speciation tests endorsed by WHO in 2007.
    van Kampen SC; Oskam L; Tuijn CJ; Klatser PR
    PLoS One; 2012; 7(8):e43439. PubMed ID: 22937050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is deployement of diagnostic test alone enough? Comprehensive package of interventions to strengthen TB laboratory network: three years of experience in Burkina Faso.
    Alagna R; Combary A; Tagliani E; Sawadogo LT; Saouadogo T; Diandé S; Ouedraogo F; Cirillo DM
    BMC Infect Dis; 2021 Apr; 21(1):346. PubMed ID: 33849486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast of survey results between state and a cohort of nonstate mycobacteriology laboratories: changes in laboratory practices.
    Denniston MM; Bird BR; Kelley KA
    J Clin Microbiol; 1997 Feb; 35(2):422-6. PubMed ID: 9003609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the Xpert MTB/RIF assay in the diagnosis of tuberculosis in formalin-fixed, paraffin-embedded tissues.
    Polepole P; Kabwe M; Kasonde M; Tembo J; Shibemba A; O'Grady J; Kapata N; Zumla A; Bates M
    Int J Mycobacteriol; 2017; 6(1):87-93. PubMed ID: 28317811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xpert
    Kohli M; Schiller I; Dendukuri N; Dheda K; Denkinger CM; Schumacher SG; Steingart KR
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012768. PubMed ID: 30148542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The New Xpert MTB/RIF Ultra: Improving Detection of
    Chakravorty S; Simmons AM; Rowneki M; Parmar H; Cao Y; Ryan J; Banada PP; Deshpande S; Shenai S; Gall A; Glass J; Krieswirth B; Schumacher SG; Nabeta P; Tukvadze N; Rodrigues C; Skrahina A; Tagliani E; Cirillo DM; Davidow A; Denkinger CM; Persing D; Kwiatkowski R; Jones M; Alland D
    mBio; 2017 Aug; 8(4):. PubMed ID: 28851844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
    Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
    BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of establishing a biosafety level 3 tuberculosis culture laboratory of acceptable quality standards in a resource-limited setting: an experience from Uganda.
    Ssengooba W; Gelderbloem SJ; Mboowa G; Wajja A; Namaganda C; Musoke P; Mayanja-Kizza H; Joloba ML
    Health Res Policy Syst; 2015 Jan; 13():4. PubMed ID: 25589057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Standardization of laboratory tests for tuberculosis and their proficiency testing].
    Abe C
    Kekkaku; 2003 Aug; 78(8):541-51. PubMed ID: 14509226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterial testing in clinical laboratories that participate in the College of American Pathologists Mycobacteriology Surveys. Changes in practices based on responses to 1992, 1993, and 1995 questionnaires.
    Woods GL; Long TA; Witebsky FG
    Arch Pathol Lab Med; 1996 May; 120(5):429-35. PubMed ID: 8639044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Xpert MTB/RIF assay in children with presumed pulmonary tuberculosis in Papua New Guinea.
    Kasa Tom S; Welch H; Kilalang C; Tefuarani N; Vince J; Lavu E; Johnson K; Magaye R; Duke T
    Paediatr Int Child Health; 2018 May; 38(2):97-105. PubMed ID: 28490246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three year evaluation of Xpert MTB/RIF in a low prevalence tuberculosis setting: A Scottish perspective.
    Parcell BJ; Jarchow-MacDonald AA; Seagar AL; Laurenson IF; Prescott GJ; Lockhart M
    J Infect; 2017 May; 74(5):466-472. PubMed ID: 28237624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Xpert MTB/RIF assay for diagnosis of tuberculosis and rifampin resistance in county-level laboratories in Hunan province, China.
    Hu P; Bai L; Liu F; Ou X; Zhang Z; Yi S; Chen Z; Gong D; Liu B; Guo J; Tan Y
    Chin Med J (Engl); 2014; 127(21):3744-50. PubMed ID: 25382330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Best approaches to drug-resistance surveillance at the country level.
    Cabibbe AM; Cirillo DM
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S40-S41. PubMed ID: 28043601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.